{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"C4 Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"CCCC"},"Address":{"label":"Address","value":"490 ARSENAL WAY,SUITE 200 SUITE 120, WATERTOWN, Massachusetts, 02472, United States"},"Phone":{"label":"Phone","value":"+1 617 231-0700"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.c4therapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Andrew J. Hirsch","title":"President, Chief Executive Officer & Director"},{"name":"Leonard M. J. Reyno","title":"Chief Medical Officer"},{"name":"Mayra Reyes-Armour","title":"SVP-Technical Operations, Quality & Facilities"},{"name":"Michelle Mahler","title":"Vice President-Clinical Development"},{"name":"Paige Mahaney","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}